Yu L - Search Results

1

Immunochemotherapy for small cell lung cancer with paraneoplastic Cushing syndrome: A case report and literature review.

Yu L, Li Y, Li C, Qi X, Lin Y, Li Y, Chen H, Lin L. Yu L, et al. Medicine (Baltimore). 2024 Dec 20;103(51):e41036. doi: 10.1097/MD.0000000000041036. Medicine (Baltimore). 2024. PMID: 39705446 Free PMC article. Review.

2

Management of small cell lung cancer complicated with paraneoplastic Cushing's syndrome: a systematic literature review.

Li Y, Li C, Qi X, Yu L, Lin L. Li Y, et al. Among authors: yu l. Front Endocrinol (Lausanne). 2023 Oct 17;14:1177125. doi: 10.3389/fendo.2023.1177125. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37916144 Free PMC article.

3

Non-α-fetoprotein-producing adrenal hepatoid adenocarcinoma: A case report and literature review.

Lin J, Cao Y, Yu L, Lin L. Lin J, et al. Among authors: yu l. Medicine (Baltimore). 2018 Sep;97(39):e12336. doi: 10.1097/MD.0000000000012336. Medicine (Baltimore). 2018. PMID: 30278510 Free PMC article. Review.

4

Tanshinone IIA combined with cisplatin synergistically inhibits non-small-cell lung cancer in vitro and in vivo via down-regulating the phosphatidylinositol 3-kinase/Akt signalling pathway.

Liao XZ, Gao Y, Huang S, Chen ZZ, Sun LL, Liu JH, Chen HR, Yu L, Zhang JX, Lin LZ. Liao XZ, et al. Among authors: yu l. Phytother Res. 2019 Sep;33(9):2298-2309. doi: 10.1002/ptr.6392. Epub 2019 Jul 3. Phytother Res. 2019. PMID: 31268205 Free PMC article.

5

Rosmarinic acid reverses non-small cell lung cancer cisplatin resistance by activating the MAPK signaling pathway.

Liao XZ, Gao Y, Sun LL, Liu JH, Chen HR, Yu L, Chen ZZ, Chen WH, Lin LZ. Liao XZ, et al. Among authors: yu l. Phytother Res. 2020 May;34(5):1142-1153. doi: 10.1002/ptr.6584. Epub 2020 Jan 27. Phytother Res. 2020. PMID: 31985119 Free PMC article.

6

A refractory case of CDK4-amplified spinal astrocytoma achieving complete response upon treatment with a Palbociclib-based regimen:a case report.

Lin J, Yu L, Fu Y, Chen H, Zheng X, Wang S, Gao C, Cao Y, Lin L. Lin J, et al. Among authors: yu l. BMC Cancer. 2020 Jul 8;20(1):630. doi: 10.1186/s12885-020-07061-3. BMC Cancer. 2020. PMID: 32641004 Free PMC article.

7

Case Report: Clinical benefit from multi-target tyrosine kinase inhibitor and PARP inhibitor in a patient with cancer of unknown primary with BRCA1 large genomic rearrangement.

Yu L, Lin J, Li H, Sun L, Wang S, Chen Y, Chen H, Lin L. Yu L, et al. Front Pharmacol. 2023 Jan 23;14:997760. doi: 10.3389/fphar.2023.997760. eCollection 2023. Front Pharmacol. 2023. PMID: 36755949 Free PMC article.

8

[Treatment of late stage liver cancer by Chinese herbs combined sunitinib in one case].

Yu L, Lin LZ. Yu L, et al. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2014 Jun;34(6):758-9. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2014. PMID: 25046962 Chinese. No abstract available.

9

Prediction and verification of benignancy and malignancy of pulmonary nodules based on inflammatory related biological markers.

Zhang Z, Wu W, Li X, Lin S, Lei Q, Yu L, Lin J, Sun L, Zhang H, Lin L. Zhang Z, et al. Among authors: yu l. Heliyon. 2024 Jul 21;10(15):e34585. doi: 10.1016/j.heliyon.2024.e34585. eCollection 2024 Aug 15. Heliyon. 2024. PMID: 39144966 Free PMC article.

10

Retinal dehydrogenase 5 (RHD5) attenuates metastasis via regulating HIPPO/YAP signaling pathway in Hepatocellular Carcinoma.

Hu H, Xu L, Luo SJ, Xiang T, Chen Y, Cao ZR, Zhang YJ, Mo Z, Wang Y, Meng DF, Yu L, Lin LZ, Zhang SJ. Hu H, et al. Among authors: yu l. Int J Med Sci. 2020 Jul 19;17(13):1897-1908. doi: 10.7150/ijms.46091. eCollection 2020. Int J Med Sci. 2020. PMID: 32788868 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26,054 results

Search Page

Filters